A Comparison of Continuous Glucose Monitoring Estimated Hemoglobin A1c in Adults with Type 1 or Type 2 Diabetes
- 28 February 2023
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 25 (3) , 178-185
Abstract
Background: The relationship of mean glucose measured with continuous glucose monitoring (CGM) and hemoglobin A1c ( HbA1c) shows considerable variability between individuals with diabetes and may be influenced by race-related factors. Whether the relationship of mean glucose with HbA1c varies according to type 1 diabetes (T1D) or type 2 diabetes (T2D) has not been well evaluated. Methods: Data from 343 participants in four clinical trials (191 with T1D and 152 with T2D) were analyzed. Least squares linear regression models were fit with HbA1c as the dependent variable and mean glucose as the independent variable. Results: Mean age was 57 ± 15 years in the T1D cohort and 58 ± 10 years in the T2D cohort. The T1D cohort was 89% White non-Hispanic, 5% African American, 3% Hispanic, and 3% other or mixed race compared with 52%, 16%, 22%, and 9%, respectively, in the T2D cohort. The relationship between CGM-measured mean glucose and laboratory-measured HbA1c significantly differed between T1D and T2D cohorts, with HbA1c on average being higher with T2D than T1D for the same mean glucose ( P = 0.002). However, this difference was largely attributable to the difference in the proportion of African Americans between T1D and T2D; and after stratifying by race, the mean glucose-HbA1c relationship showed only a small difference between T1D non-African Americans and T2D non-African Americans. The mean glucose-HbA1c relationship appeared similar for White non-Hispanic and Hispanic individuals. Conclusion: HbA1c on average was higher in T2D than T1D for a given mean glucose, but after accounting for race, there was no meaningful difference in the mean glucose-HbA1c relationship comparing T1D and T2D. The mean glucose-HbA1c relationship differs in African American compared with White individuals, but does not appear to differ comparing White non-Hispanic to Hispanic individuals. The published glucose management indicator formula appears to be suitable for both T1D and T2D.Keywords
This publication has 30 references indexed in Scilit:
- Metrics to Evaluate Quality of Glycemic Control: Comparison of Time in Target, Hypoglycemic, and Hyperglycemic Ranges with “Risk Indices”Diabetes Technology & Therapeutics, 2018
- Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic ControlDiabetes Technology & Therapeutics, 2018
- Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin InjectionsAnnals of Internal Medicine, 2017
- Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c LevelsAnnals of Internal Medicine, 2017
- The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be MisleadingDiabetes Care, 2017
- Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin InjectionsJAMA, 2017
- Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoringScience Translational Medicine, 2016
- Class Effect of Erythropoietin Therapy on Hemoglobin A1c in a Patient with Diabetes Mellitus and Chronic Kidney Disease Not Undergoing HemodialysisPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2009
- Translating the A1C Assay Into Estimated Average Glucose ValuesDiabetes Care, 2008
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993